EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Itraconazole inhibits tumor growth via CEBPB ‐mediated glycolysis in colorectal cancer

Yong Zhang iD, Lu Li, Feifei Chu, Huili Wu iD, Xingguo Xiao, Jianping Ye, Kunkun Li

Cancer Science · 2024

DOI: 10.1111/cas.16082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Yong Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Branch Center of Advanced Medical Research Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Itraconazole, Colorectal Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Henan provincial Medical Science and Technology Research Project, the Key Scientific Research Project of University in Henan Province, the Youth Project of Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Advanced colorectal cancer (CRC) is characterized by a high recurrence and metastasis rate, which is the primary cause of patient mortality. Unfortunately, effective anti‐cancer drugs for CRC are still lacking in clinical practice. We screened FDA‐approved drugs by utilizing targeted organoid sequencing data and found that the antifungal drug itraconazole had a potential therapeutic effect on CRC tumors. However, the effect and mechanism of itraconazole on CRC tumors have not been investigated. A cell line‐derived xenograft model in tumor‐bearing mice was established and single‐cell RNA sequencing was performed on tumor samples from four mice with or without itraconazole treatment. The proportion of cell populations and gene expression profiles was significantly different between the two groups. We found that itraconazole could inhibit tumor growth and glycolysis. We revealed that CEBPB was a new target for itraconazole, and that silencing CEBPB could repress CRC glycolysis and tumor growth by inhibiting ENO1 expression. Clinical analysis showed that CEBPB expression was obviously elevated in CRC patients, and was associated with poor survival. In summary, itraconazole treatment remodeled cell composition and gene expression profiles. Itraconazole inhibited cell glycolysis and tumor growth via the CEBPB–ENO1 axis. In this study, we illustrate a new energy metabolism mechanism for itraconazole on tumor growth in CRC that will provide a theoretical basis for CRC targeting/combination therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ItraconazoleColorectal NeoplasmsHumansAnimalsMiceCell Line, TumorDisease Models, AnimalGlycolysisCell ProliferationGene Expression Regulation, NeoplasticCCAAT-Enhancer-Binding Protein-beta

Stichwörter der Autor:innen

CEBPBcolorectal cancerglycolysisitraconazolesingle‐cell RNA sequencing

Substanzen

ItraconazoleCEBPB protein, humanCCAAT-Enhancer-Binding Protein-beta

Autor:innen und Institutionen

  • Branch Center of Advanced Medical Research Center, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
  • Department of Gastroenterology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China.
  • Medical Key Laboratory for Diagnosis and Treatment of Colorectal Cancer in Henan Province, Zhengzhou, China.
  • Zhengzhou Key Laboratory for Diagnosis, Treatment and Research of Colorectal Cancer, Zhengzhou, China.

ORCID-Profile: Yong Zhang, Huili Wu

Förderung

  • Henan provincial Medical Science and Technology Research Project
  • the Key Scientific Research Project of University in Henan Province
  • the Youth Project of Natural Science Foundation of China
  • the Research Start-up Fund Project of Zhengzhou Central Hospital

Zitieren

APA

Zhang, Y., Li, L., Chu, F., Wu, H., Xiao, X., Ye, J., & Li, K. (2024). Itraconazole inhibits tumor growth via CEBPB ‐mediated glycolysis in colorectal cancer. Cancer Science. https://doi.org/10.1111/cas.16082

Vancouver

Zhang Y, Li L, Chu F, Wu H, Xiao X, Ye J, et al. Itraconazole inhibits tumor growth via CEBPB ‐mediated glycolysis in colorectal cancer. Cancer Science. 2024. doi:10.1111/cas.16082

BibTeX
@article{Zhang2024,
  author = {Zhang, Yong and Li, Lu and Chu, Feifei and Wu, Huili and Xiao, Xingguo and Ye, Jianping and Li, Kunkun},
  title = {Itraconazole inhibits tumor growth via CEBPB ‐mediated glycolysis in colorectal cancer},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16082}
}
Kostenlos starten →